{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T17:04:42Z","timestamp":1789751082029,"version":"4.0.1"},"reference-count":17,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.es","elsevier.es","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Archivos de Bronconeumolog\u00eda"],"published-print":{"date-parts":[[2023,12]]},"DOI":"10.1016\/j.arbres.2023.09.012","type":"journal-article","created":{"date-parts":[[2023,9,28]],"date-time":"2023-09-28T21:24:45Z","timestamp":1695936285000},"page":"839-841","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Bronchiectasis in Subjects With Chronic Lymphocytic Leukemia"],"prefix":"10.1016","volume":"59","author":[{"given":"Dovev","family":"Cohen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandra","family":"Osadchy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keren","family":"Cohen-Hagai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Osnat","family":"Jarchowsky Dolberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lilach","family":"Israeli-Shani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Lishner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Breslavsky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Shitrit","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ori","family":"Wand","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.arbres.2023.09.012_bib0090","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1378\/chest.11-1024","article-title":"Bronchiectasis in a diverse US population: effects of ethnicity on etiology and sputum culture","volume":"142","author":"McShane","year":"2012","journal-title":"Chest"},{"key":"10.1016\/j.arbres.2023.09.012_bib0095","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1016\/j.clml.2023.02.001","article-title":"SOHO State of the Art Updates and Next Questions | Infections in chronic lymphocytic leukemia patients: risks and management","volume":"23","author":"Gargiulo","year":"2023","journal-title":"Clin Lymphoma Myeloma Leuk"},{"key":"10.1016\/j.arbres.2023.09.012_bib0100","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.ejca.2016.11.020","article-title":"Major infections, secondary cancers and autoimmune diseases occur in different clinical subsets of chronic lymphocytic leukaemia patients","volume":"72","author":"Visentin","year":"2017","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.arbres.2023.09.012_bib0105","doi-asserted-by":"crossref","first-page":"2883","DOI":"10.1002\/cncr.29438","article-title":"Hypogammaglobulinemia in newly diagnosed chronic lymphocytic leukemia: natural history, clinical correlates, and outcomes","volume":"121","author":"Parikh","year":"2015","journal-title":"Cancer"},{"key":"10.1016\/j.arbres.2023.09.012_bib0110","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1016\/j.chest.2017.06.042","article-title":"De Novo development of bronchiectasis in patients with hematologic malignancy","volume":"152","author":"Chen","year":"2017","journal-title":"Chest"},{"key":"10.1016\/j.arbres.2023.09.012_bib0115","doi-asserted-by":"crossref","DOI":"10.1183\/23120541.00166-2019","article-title":"De novo bronchiectasis in haematological malignancies: patient characteristics, risk factors and survival","volume":"5","author":"Jos\u00e9","year":"2019","journal-title":"ERJ Open Res"},{"key":"10.1016\/j.arbres.2023.09.012_bib0120","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1016\/S2213-2600(21)00277-0","article-title":"Criteria and definitions for the radiological and clinical diagnosis of bronchiectasis in adults for use in clinical trials: international consensus recommendations","volume":"10","author":"Aliberti","year":"2022","journal-title":"Lancet Respir Med"},{"key":"10.1016\/j.arbres.2023.09.012_bib0125","doi-asserted-by":"crossref","first-page":"274","DOI":"10.3390\/curroncol30010022","article-title":"A retrospective study on the efficacy of subcutaneous immunoglobulin as compared to intravenous formulation in patients with chronic lymphocytic leukemia and secondary antibody deficiency","volume":"30","author":"Visentin","year":"2022","journal-title":"Curr Oncol"},{"key":"10.1016\/j.arbres.2023.09.012_bib0130","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1016\/j.chest.2019.05.009","article-title":"Common variable immune deficiency and associated complications","volume":"156","author":"Gupta","year":"2019","journal-title":"Chest"},{"key":"10.1016\/j.arbres.2023.09.012_bib0135","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1080\/17476348.2022.2043746","article-title":"Airway disease in hematologic malignancies","volume":"16","author":"Jos\u00e9","year":"2022","journal-title":"Expert Rev Respir Med"},{"key":"10.1016\/j.arbres.2023.09.012_bib0140","doi-asserted-by":"crossref","first-page":"310","DOI":"10.5603\/ARM.a2018.0050","article-title":"Development of bronchiectasis during long-term rituximab treatment for rheumatoid arthritis","volume":"86","author":"Santos","year":"2018","journal-title":"Adv Respir Med"},{"key":"10.1016\/j.arbres.2023.09.012_bib0145","first-page":"100904","article-title":"Marked deterioration in rheumatoid arthritis associated bronchiectasis following treatment with rituximab","volume":"28","author":"Musameh","year":"2019","journal-title":"Respir Med Case Rep"},{"key":"10.1016\/j.arbres.2023.09.012_bib0150","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1148\/radiol.212547","article-title":"Bronchiectasis in low-dose CT screening for lung cancer","volume":"304","author":"Cai","year":"2022","journal-title":"Radiology"},{"key":"10.1016\/j.arbres.2023.09.012_bib0155","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1111\/bjh.14785","article-title":"Relationship between co-morbidities at diagnosis, survival and ultimate cause of death in patients with chronic lymphocytic leukaemia (CLL): a prospective cohort study","volume":"178","author":"Strati","year":"2017","journal-title":"Br J Haematol"},{"key":"10.1016\/j.arbres.2023.09.012_bib0160","doi-asserted-by":"crossref","first-page":"e300","DOI":"10.3324\/haematol.2017.182006","article-title":"Predictors of infection among patients prior to treatment of chronic lymphocytic leukemia: a Danish nationwide cohort study","volume":"103","author":"Andersen","year":"2018","journal-title":"Haematologica"},{"key":"10.1016\/j.arbres.2023.09.012_bib0165","doi-asserted-by":"crossref","first-page":"16096","DOI":"10.1038\/nrdp.2016.96","article-title":"Chronic lymphocytic leukaemia","volume":"3","author":"Kipps","year":"2017","journal-title":"Nat Rev Dis Primers"},{"key":"10.1016\/j.arbres.2023.09.012_bib0170","doi-asserted-by":"crossref","first-page":"1896","DOI":"10.1016\/j.chest.2020.05.598","article-title":"Treatment of community-acquired pneumonia in immunocompromised adults: a consensus statement regarding initial strategies","volume":"158","author":"Ramirez","year":"2020","journal-title":"Chest"}],"container-title":["Archivos de Bronconeumolog\u00eda"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0300289623003083?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0300289623003083?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,3]],"date-time":"2025-10-03T22:43:19Z","timestamp":1759531399000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0300289623003083"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12]]},"references-count":17,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2023,12]]}},"alternative-id":["S0300289623003083"],"URL":"https:\/\/doi.org\/10.1016\/j.arbres.2023.09.012","relation":{},"ISSN":["0300-2896"],"issn-type":[{"value":"0300-2896","type":"print"}],"subject":[],"published":{"date-parts":[[2023,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Bronchiectasis in Subjects With Chronic Lymphocytic Leukemia","name":"articletitle","label":"Article Title"},{"value":"Archivos de Bronconeumolog\u00eda","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.arbres.2023.09.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 SEPAR. Published by Elsevier Espa\u00f1a, S.L.U. All rights reserved.","name":"copyright","label":"Copyright"}]}}